Impact of Ramadan fasting on glucose levels in women with gestational diabetes mellitus treated with diet alone or diet plus metformin: a continuous glucose monitoring study

• Published in: BMJ open diabetes research & care Vol. 5; no. 1; p. e000470
• Main Authors: Afandi, Bachar O, Hassanein, Mohamed M, Majd, Lina M, Nagelkerke, Nico J D
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group 01-12-2017
• Subjects: Emerging Technologies, Pharmacology and Therapeutics; fasting; gestational diabetes mellitus; continuous glucose monitoring; hypoglycemia
• ISSN: 2052-4897; 2052-4897
• DOI: 10.1136/bmjdrc-2017-000470

ObjectiveWomen with gestational diabetes mellitus (GDM) are categorized as at high risk for adverse events during Ramadan fasting. However, this is largely based on clinical opinion. In this study, we shed some light on what happens to glucose levels during Ramadan fasting.MethodsThis is a prospective observational study. A total of 32 patients with GDM were recruited; 10 patients, treated with diet only (group 1), to observe their glucose levels before fasting and 22 patients who insisted on fasting the month of Ramadan, 13 treated with diet only (group 2) and nine treated with diet plus metformin 500 mg twice daily (group 3), to evaluate their glucose levels during fasting. Interstitial glucose was monitored in all by using the iPro2 Professional continuous glucose monitoring (CGM) system.ResultsMean glucose level was 116±21 mg/dL (6.16±1.16 mmol/L), 106±9 mg/dL (5.88±0.49 mmol/L) and 99±7 mg/dL (5.49±0.34 mmol/L) in groups 1, 2 and 3, respectively. Patients in group 1 had the lowest rate of hypoglycemia (50%), followed by patients in group 2 (60%), whereas patients in group 3 had the highest rate of hypoglycemia (78%).ConclusionsCGM data indicates that Ramadan fasting in women with GDM treated with diet alone or with diet plus metformin was associated with lower mean glucose levels and higher rates of hypoglycemia when compared with non-fasting glucose levels. Women with GDM should be advised against fasting during Ramadan until further data is available.